Clinical Trial Update: Molecular Biology of Anal Cancer in HIV-Positive Patients

View source ↗

Summary

The clinical trial updating the molecular biology of anal cancer in HIV-positive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• HIV Infection

Snippet

Sponsor: University Hospital, Geneva | Conditions: Carcinoma, HIV Infections | Status: COMPLETED